中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2023-12-08
Next Day Disclosure Returns - Share Buyback
2023-12-07
Next Day Disclosure Returns - Share Buyback
2023-12-06
Next Day Disclosure Returns - Share Buyback
2023-12-05
Voluntary Announcement - Ascletis Announces Initiation of Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
2023-12-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
2023-12-05
Next Day Disclosure Returns - Share Buyback
2023-12-04
Next Day Disclosure Returns - Share Buyback
2023-12-01
Next Day Disclosure Returns - Share Buyback
2023-11-30
Next Day Disclosure Returns - Share Buyback
2023-11-29
«
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
